Inaktiver Wert

Andere Sprachen Aerie Pharmaceuticals, Inc.

Aktien

A1W7RL

US00771V1089

AERI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Bourse Zurich: les indices finissent de peu dans le rouge	22.11.22
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company's Ophthalmic Pharmaceutical Business	22.11.22
Alcon : l'acquisition d'Aerie Pharmaceuticals est bouclée	22.11.22
Bourse Zurich: détente sensible à l'approche de la mi-journée	22.11.22
Alcon Completes Acquisition of Aerie Pharmaceuticals for $930 Million	22.11.22
Alcon: conclusa acquisizione Aerie Pharmaceuticals	22.11.22
Alcon finalise le rachat de l'américain Aerie Pharmaceuticals	22.11.22
Alcon Concludes $930 Million Purchase of US-based Aerie Pharmaceuticals	22.11.22
AERIE PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements an (form 8-K)	21.11.22
Aerie Pharmaceuticals, Inc. Announces Executive Changes	21.11.22
Aerie Pharmaceuticals, Inc. Announces Executive Changes	21.11.22
Aerie Pharmaceuticals, Inc. Announces Management Changes	21.11.22
Aerie Pharmaceuticals, Inc.(NasdaqGM:AERI) dropped from NASDAQ Composite Index	21.11.22
Aerie Pharmaceuticals, Inc.(NasdaqGM:AERI) dropped from S&P TMI Index	21.11.22
Aerie Pharmaceuticals, Inc.(NasdaqGM:AERI) dropped from S&P Global BMI Index	21.11.22
Alcon Research, Ltd. completed the acquisition of Aerie Pharmaceuticals, Inc. from a group of shareholders.	21.11.22
AERIE PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders (form 8-K)	18.11.22
Aerie Pharmaceuticals, Inc.(NasdaqGM:AERI) dropped from NASDAQ Biotechnology Index	18.11.22
Prévisions Alcon: recettes de 2,1 milliards de dollars au 3e trimestre	15.11.22
Aerie Pharmaceuticals : Merger Agreement - Form 8-K	07.11.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Aerie Pharmaceuticals, Inc.

Aktien

A1W7RL

US00771V1089

AERI

Andere Sprachen

Filter